Preliminary Examination of Olanzapine and Diet Interactions on Metabolism in a Female Macaque
Journal Title: Journal of Endocrinology and Diabetes - Year 2015, Vol 2, Issue 2
Abstract
Clinical data suggest that atypical antipsychotics such as Olanzapine (OLZ) induce significant metabolic changes that are serious side effects of their primary use. Since controlled human studies are problematic and rodent data may be poorly translatable, we have initiated development of a macaque model of OLZ-induced metabolic disease. In this preliminary feasibility study, we examined some metabolic effects of OLZ in a female macaque in the context of a standard low-calorie/fat monkey chow diet followed by a highfat/ sugar western-style diet (WSD). A female Japanese macaque was administered OLZ (1.25 mg/day) for 6 months, with dietary changes at 2-month intervals as follows: OLZ + Restricted chow, OLZ + Unrestricted chow, OLZ + WSD, and Placebo + WSD. Weight was assessed weekly. Glucose tolerance tests (GTT) and dexascans were performed at baseline and every 2 months. Omental (OM) and subcutaneous (SQ) adipose tissue biopsies were obtained at baseline, after OLZ + Unrestricted chow and after OLZ + WSD to evaluate adipocyte size, lipolysis, and insulin-stimulated free fatty acid uptake (FFA). A separate trial was conducted on two monkeys with 5 days of OLZ or no-treatment followed by RT-PCR on rostral and medial basal hypothalamus. Weight increased on administering OLZ + Restricted chow and stabilized on administering OLZ + Unrestricted chow. OLZ + WSD diet did not significantly change the weight plateau. Weight declined upon withdrawal of OLZ with continued WSD. Body fat increased from 14% at baseline to 22%, 30%, 28% and 19% at 2, 4, 6 and 8 months (mo), respectively, indicating that body fat was elevated on OLZ administration regardless of diet and declined upon OLZ removal. Glucose tolerance and the insulin response during GTT were normal with OLZ + Restricted chow or OLZ + Unrestricted chow diets. Addition of WSD with OLZ impaired glucose clearance during GTT. Insulin remained in the normal range, but first-phase insulin secretion was reduced. After removal of OLZ, but continued WSD administration, glucose clearance returned to normal; however, this was associated with hyperinsulinemia. Adipocyte diameter was increased in OM and SQ fat by OLZ + chow and OLZ + WSD to a similar extent (p < 0.01, 2-way ANOVA). In OM, isoproterenol-stimulated lipolysis occurred at baseline. In both depots, isoproterenol-stimulated lipolysis occurred with OLZ + chow, but it was significantly blunted by addition of WSD (ANOVA p < 0.0001; post hoc p < 0.05). Insulin increased FFA uptake at baseline. OLZ + chow or OLZ + WSD increased basal FFA uptake but insulininduced FFA uptake was blunted in both depots (post hoc p < 0.05). There was a marked decrease in pre-opiomelanocortin (POMC) gene expression, and increased agouti-related peptide (AgRP) and neuropeptide Y (NPY) expression in the hypothalamus. There was also a clear increase in serotonin (5HT) 2C, melanocortin (MCR4), and leptin (LepR) receptor gene expression. These data support the hypotheses that OLZ acts on peripheral tissues as well as in the CNS; that changes in hypothalamic gene expression occur very rapidly and precede increased fat accumulation; that adipose tissue exhibits insulin resistance prior to alterations in GTT; that addition of WSD to OLZ precipitates hyperglycemia without an obvious insulin response; and that removal of OLZ and continued WSD resulted in normalized glucose clearance and elevated insulin. These data suggest complex and early responses to OLZ that may be exacerbated by WSD.
Authors and Affiliations
Cynthia Bethea, Paul Kievit, Kenny Phu, Arubala P Reddy, Charles T Roberts Jr
Keywords
Related Articles
- EP ID EP333071
- DOI 10.15226/2374-6890/1/2/00112
- Views 111
- Downloads 0
Variation of Glycosylated Hemoglobin (HbA1C) Cutoff among type-2 diabetic nephropathy Patients
Objectives: The aim of the study was to determine glycosylated hemogobin (HbA1c) cut-off and lipid correlation, duration of diabetes with level of proteinuria. Materials And Methods: Cross sectional study was done on 25...
Factors Associated With Glycemic Control among Type 2 Diabetes Patients Attending Mathari National Teaching Hospital, Nairobi Kenya
Introduction: Type 2 Diabetes mellitus is chronic metabolic disorder characterized by hyperglycemia resulting from insulin secretion, insulin action, or both and accounts for over 95% cases globally. Uncontrolled diabete...
A New Diagnosis of Addison's Disease with a Twist
Addison's disease is a rare autoimmune endocrine disorder. It affects the cortex of the adrenal glands causing cortisol, aldosterone and adrenal androgen deficiencies. Addison's disease usually presents with non specific...
Thyroid-Induced Toxicity of Check-Point Inhibitors Immunotherapy in the Treatment of Advanced Non-Small Cell Lung Cancer
Immunotherapy represents a new strategy in the fight against cancer diseases based on the key role that immune system plays to identify and destroy foreign or abnormal cells in the body, including tumor cells. Nowadays,...
Diabetes and Physical Activity
Diabetes has been on the rise globally. Although many factors contribute to the increasing risk and manifestation of this disease lack and decreased physical activity/ exercise stands out as one of the major factors. Tre...